<?xml version="1.0" encoding="UTF-8"?>
<ref id="B195-pharmaceutics-13-00327">
 <label>195.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zielinska</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Martins-Gomes</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Ferreira</surname>
    <given-names>N.R.</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>A.M.</given-names>
   </name>
   <name>
    <surname>Nowak</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Souto</surname>
    <given-names>E.B.</given-names>
   </name>
  </person-group>
  <article-title>Anti-inflammatory and anti-cancer activity of citral: Optimization of citral-loaded solid lipid nanoparticles (SLN) using experimental factorial design and LUMiSizer(R)</article-title>
  <source>Int. J. Pharm.</source>
  <year>2018</year>
  <volume>553</volume>
  <fpage>428</fpage>
  <lpage>440</lpage>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2018.10.065</pub-id>
  <?supplied-pmid 30385373?>
  <pub-id pub-id-type="pmid">30385373</pub-id>
 </element-citation>
</ref>
